14 results found

Dheepak Arumukhom Revi, Ruoxi Wang, Franchino Porciuncula, Jenna A. Zajac, Terry Ellis, Louis Awad

Introduction: Non-invasive clinical tests that enable early detection of Parkinson’s disease (PD) can alter treatment planning and the course of the disease. Gait impairments are among the most common...

Journal of NeuroEngineering and Rehabilitation 2026-04-21 rs-9296177

Demet Timur, Mehmet Tekinsoy

Purpose Serum galactomannan (GM) testing is widely used as a mycological marker in the diagnostic work-up of invasive aspergillosis (IA), but results near the assay cut-off may vary on repeat measurem...

BMC Microbiology 2026-04-20 rs-9057396
Galactomannan invasive aspergillosis Platelia Aspergillus Ag reproducibility serum biomarker

Mr. Negewo kebede, Dr. zerihun Assefa, Mr. Bati Leta, Mr.Behonegn Birhan, Mr. Abebe Dukessa

Background: Diabetes mellitus (DM) is a metabolic disorder characterized by hyperglycemia resulting from defective insulin action, secretion or both. Liver disorders are known to be a risk factor for ...

BMC Endocrine Disorders 2026-04-20 rs-9409289
Type two DM Chronic kidney diseases liver Biomarkers

Jane Alty, Gianluca Amprimo, Jung Hwan Shin, Max Wuehr, Michal Novotny, Helga Haberfehlner, Claudia Ferraris, Renjie Li, Marcelo Merello, Marina de Koning-Tijssen, Samuel Relton, David Wong, Johannes Taeger, Andreas Zwergal, Sebastian Walther, Jochen Weishaupt, Karl Georg Häusler, Jan Rusz, Babak Taati, Ryan Roemmich, Martin McKeown, Anoopum S. Gupta, Maximilian U. Friedrich

Background: Neurological motor assessment relies on semi-quantitative, scale-based measures with inherent clinimetric limitations that disproportionately affect clinical trials aimed at early disease ...

Research Square 2026-04-20 rs-9437116
Neurology Digital Biomarkers Computer Vision Movement Analysis Videography
Back to Top
Home
Browse
Submit
About
0.049168s